Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Şeyda Gündüz"'
Publikováno v:
European Journal of Breast Health, Vol 17, Iss 4, Pp 322-327 (2021)
Objective:The aim was to investigate the effect of primary tumor resection (PTR) on survival in metastatic breast cancer patients and to assess the power of the neutrophil-to-lymphocyte ratio (NLR) regarding the prediction of prognosis in this patien
Externí odkaz:
https://doaj.org/article/2de8013017e2485985ab4fbce50c8deb
Autor:
Atakan Demir, Nil Molinas Mandel, Semra Paydas, Gökhan Demir, Özlem Er, Nazım Serdal Turhal, Sevil Bavbek, Yeşim Eralp, Pınar Mualla Saip, Emine Nilüfer Güler, Adnan Aydıner, Başak Oyan Uluç, Sadettin Kılıçkap, Necdet Üskent, Nuri Karadurmuş, Mehmet Ali Kaplan, Mustafa Teoman Yanmaz, Hacer Demir, Özkan Alan, Taner Korkmaz, Polat Olgun, Özlem Sönmez Uysal, Kadri Altundağ, Şeyda Gündüz, Meral Günaldı, Murat Sarı, İsmail Beypınar, Gül Başaran
Publikováno v:
Balkan Medical Journal, Vol 37, Iss 2, Pp 104-107 (2020)
Background:The synthesis of CDK4/6 inhibitors with endocrine treatment in two series of treatment has been widely accepted as the standard for patients with estrogen receptor-positive metastatic breast cancer. In spite of this, the activity of CDK4/6
Externí odkaz:
https://doaj.org/article/04ceb2349b6c44ffbafb27dfc640256d
Autor:
Melek Karakurt Eryılmaz, Hasan Mutlu, Şeyda Gündüz, Mükremin Uysal, Fatma Yaçın Müsri, Hasan Şenol Coşkun
Publikováno v:
Journal of Oncological Sciences, Vol 2, Iss 2, Pp 73-76 (2016)
The protective effect of sun exposure on prognosis of cancer and cancer risk was previously reported in some studies except for melanoma and skin cancer. In presented study we aimed to compare the effect of sunlight exposure on prognosis of patients
Externí odkaz:
https://doaj.org/article/6a961f2aa6c941b7941c2baa0d56bd17
Autor:
Deniz Arslan, Şeyda Gündüz, Deniz Tural, Mükremin Uysal, Ali Murat Tatlı, Cumhur İbrahim Başsorgun, Gülsüm Özlem Elpek, Hasan Şenol Coşkun, Hakan Şat Bozcuk, Burhan Savaş
Publikováno v:
Case Reports in Oncological Medicine, Vol 2013 (2013)
Inflammatory myofibroblastic tumor (IMT) is a rare mesenchymal benign tumor which is generally seen in children and in young adults. It is especially located in the lungs. In histopathological examination, neoplastic fusiform cells originating from a
Externí odkaz:
https://doaj.org/article/acdc3a496a3d405ca48f72aed9cfc91e
Autor:
Şeyda GÜNDÜZ, Dilek ERDEM, Deniz Can GÜVEN, Sercan AKSOY, Mükremin UYSAL, Aysegül KARGI, Akın YILDIZ, İrem KARAMAN, Mustafa ÖZDOĞAN
Publikováno v:
Journal of Oncological Sciences. 7:85-90
Autor:
Mehmet Ali Kaplan, Sevil Bavbek, Ozkan Alan, Gokhan Demir, Pinar Saip, Yesim Eralp, Semra Paydas, Nazım Serdal Turhal, Atakan Demir, Necdet Uskent, Özlem Sönmez Uysal, Emine Nilufer Guler, Adnan Aydiner, Kadri Altundag, Taner Korkmaz, Hacer Demir, Mustafa Teoman Yanmaz, Ismail Beypinar, Başak Oyan Uluç, Şeyda Gündüz, Sadettin Kilickap, Polat Olgun, Nil Molinas Mandel, Murat Sari, Ozlem Er, Nuri Karadurmuş, G. Basaran, Meral Gunaldi
Publikováno v:
Balkan Medical Journal, Vol 37, Iss 2, Pp 104-107 (2020)
Balkan Medical Journal
Balkan Medical Journal
WOS:000518031100008 PMID: 31970972 Background: The synthesis of CDK4/6 inhibitors with endocrine treatment in two series of treatment has been widely accepted as the standard for patients with estrogen receptor-positive metastatic breast cancer. In s
Autor:
Mehmet Artac, Ozgur Tanriverdi, Osman Kostek, Ahmet Dirican, Özge Keskin, Nail Paksoy, Ali Alkan, Müge Sönmez, Mustafa Yildirim, Şeyda Gündüz, Zuhat Urakci, Ahmet Taner Sümbül, Semra Paydas, Kerem Oruc, Deniz Tural, Birol Yildiz, Ali Osman Kaya, Burcu Çakar, Meltem Ekenel, Fatih Selcukbiricik, Irem Bilgetekin, Fatma Paksoy Turkoz, Yuksel Urun, Mustafa Erman, Meltem Selam, Nail Özhan, Ömer Fatih Ölmez, Halil Taskaynatan, Saadettin Kilickap, Elif Atag, Selami Bayram, Deniz Tataroğlu Özyükseler, Dilek Erdem, Sabri Güncan, Tugba Basoglu, Mehmet Ali Nahit Sendur, Hasan Şenol Coşkun
Background: Atezolizumab (ATZ) has demonstrated antitumor activity and manageable safety in previous studies of patients with metastatic platinum-resistant urothelial carcinoma. However, the response rate of Atezolizumab was modest. In the current st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ad0808c1ae34df687e136a5aa5ec7ca
https://avesis.deu.edu.tr/publication/details/8d62a86a-0e4f-4339-9426-b0070cd55957/oai
https://avesis.deu.edu.tr/publication/details/8d62a86a-0e4f-4339-9426-b0070cd55957/oai
Autor:
Atakan Demir, Nil Molinas Mandel, Semra Paydas, Gökhan Demir, Özlem Er, Nazım Serdal Turhal, Sevil Bavbek, Yeşim Eralp, Pınar Mualla Saip, Nilüfer Güler, Adnan Aydıner, Başak Oyan Uluç, Sadettin Kılıçkap, Necdet Üskent, Nuri Karadurmuş, Mehmet Ali Kaplan, Mustafa Teoman, Teoman Yanmaz, Hacer Demir, Özkan Alan, Taner Korkmaz, Polat Olgun, Özlem Sönmez Uysal, Kadri Altundağ, Şeyda Gündüz, Meral Günaldı, Murat Sarı, İsmail Beypınar, Gül Başaran
Publikováno v:
Balkan Medical Journal.
Autor:
Ahmet Taner Sümbül, Osman Kostek, Deniz Tural, Fatma Paksoy Turkoz, Şeyda Gündüz, Mehmet Artac, Ömer Fatih Ölmez, Mustafa Yildirim, Dilek Erdem, Ali Osman Kaya, Yuksel Urun, Meltem Ekenel, Birol Yildiz, Ali Alkan, Emre Akar, Nail Özhan, Halil Taskaynatan, Özge Keskin, Mehmet Ali Nahit Sendur, Deniz Tataroğlu Özyükseler, Zuhat Urakci, Nail Paksoy, Ozgur Tanriverdi, Sabri Güncan, Ugur Yilmaz, Irem Bilgetekin, Elif Atag, Kerem Oruc, Mustafa Erman, Meltem Selam, Hasan Şenol Coşkun, Ahmet Dirican, Müge Sönmez, Tugba Basoglu, Selami Bayram, Burcu Çakar, Fatih Selcukbiricik, Semra Paydas, Saadettin Kilickap
[No abstract available]
Amer Soc Clin Oncol
Amer Soc Clin Oncol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5dc593e73ea82bc330c89132a0963f04
https://doi.org/10.1016/j.euf.2020.09.010
https://doi.org/10.1016/j.euf.2020.09.010
Autor:
Hasan, Mutlu, Derya Kıvrak, Salim, Şeyda, Gündüz, Melek Karakurt, Eryılmaz, Fatma Yalçın, Musri, Hasan Şenol, Coşkun
Publikováno v:
Journal of Cancer Research and Therapeutics, Vol 13, Iss 3, Pp 510-513 (2017)
Background: The prognosis of recurrent or metastatic head and neck squamous cell cancer (HNSCC) is very poor. In the present retrospective study, we compared the impact of docetaxel plus cisplatin plus fluorouracil (TCF), and cisplatin plus fluoroura